Literature DB >> 29253182

Findings of Thyroid Ultrasound Examination Within 3 Years After the Fukushima Nuclear Power Plant Accident: The Fukushima Health Management Survey.

Hiroki Shimura1,2, Tomotaka Sobue3, Hideto Takahashi1, Seiji Yasumura1,4, Tetsuya Ohira1,5, Akira Ohtsuru1,6, Sanae Midorikawa1,6, Satoru Suzuki1, Toshihiko Fukushima7, Shinichi Suzuki7, Shunichi Yamashita1,8, Hitoshi Ohto1.   

Abstract

Context: Childhood thyroid cancer is of great concern after the Fukushima nuclear power plant accident. Baseline analytical data on thyroid ultrasound examination (TUE) in children are important for future studies. Objective: We analyzed the age and sex distribution of findings from the TUEs of children and adolescents in the Fukushima Health Management Survey (FHMS). Design, Setting, and Participants: From October 2011 through March 2014, 294,905 participants aged 18 years or younger at the time of the earthquake voluntarily had TUEs in the first round of the FHMS. A secondary confirmatory examination was performed in 2032 subjects. Age- and sex-dependent prevalence and size of thyroid cysts, nodules, and cancers were analyzed. Main Outcome Measures: Age, sex, and size distribution of findings were analyzed.
Results: Thyroid cysts, nodules, and cytologically suspected cancers were detected in 68,009, 1415, and 38 male subjects and in 73,014, 2455, and 74 female subjects, respectively. There was an age-dependent increase in the detection rate of thyroid nodules and cancer, but that of cysts reached a peak at 11 to 12 years. Sex affected the prevalence of thyroid nodules and cancers after the onset of puberty, but only a small difference was exhibited in that of cysts. Conclusions: The thyroid cancer detection rate in Fukushima was clarified, and the proportion of individuals with thyroid nodules and cysts varied substantially by age. The results of this study will contribute to future epidemiological research on nodular thyroid diseases in children and adolescents.

Entities:  

Mesh:

Year:  2018        PMID: 29253182     DOI: 10.1210/jc.2017-01603

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  5 in total

1.  Thyroid Abnormalities in Patients With Extreme Insulin Resistance Syndromes.

Authors:  Yevgeniya S Kushchayeva; Sergiy V Kushchayev; Megan Startzell; Elaine Cochran; Sungyoung Auh; Yuhai Dai; Marissa Lightbourne; Monica Skarulis; Rebecca J Brown
Journal:  J Clin Endocrinol Metab       Date:  2019-06-01       Impact factor: 5.958

2.  Incidence of Thyroid Cancer Among Children and Young Adults in Fukushima, Japan, Screened With 2 Rounds of Ultrasonography Within 5 Years of the 2011 Fukushima Daiichi Nuclear Power Station Accident.

Authors:  Akira Ohtsuru; Sanae Midorikawa; Tetsuya Ohira; Satoru Suzuki; Hideto Takahashi; Michio Murakami; Hiroki Shimura; Takashi Matsuzuka; Seiji Yasumura; Shin-Ichi Suzuki; Susumu Yokoya; Yuko Hashimoto; Akira Sakai; Hitoshi Ohto; Shunichi Yamashita; Koichi Tanigawa; Kenji Kamiya
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2019-01-01       Impact factor: 6.223

3.  Association between the detection rate of thyroid cancer and the external radiation dose-rate after the nuclear power plant accidents in Fukushima, Japan.

Authors:  Hidehiko Yamamoto; Keiji Hayashi; Hagen Scherb
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

4.  Trend in Cancer Incidence and Mortality in Fukushima From 2008 Through 2015.

Authors:  Akiko Shibata; Shigehira Saji; Kenji Kamiya; Seiji Yasumura
Journal:  J Epidemiol       Date:  2021-02-18       Impact factor: 3.211

5.  Nested matched case control study for the Japan Fukushima Health Management Survey's first full-scale (second-round) thyroid examination.

Authors:  Hideto Takahashi; Seiji Yasumura; Kunihiko Takahashi; Tetsuya Ohira; Akira Ohtsuru; Sanae Midorikawa; Satoru Suzuki; Hiroki Shimura; Tetsuo Ishikawa; Akira Sakai; Shinichi Suzuki; Susumu Yokoya; Koichi Tanigawa; Hitoshi Ohto; Kenji Kamiya
Journal:  Medicine (Baltimore)       Date:  2020-07-02       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.